"Ascension Via Christi Hospital in Pittsburg, Kansas, is a full-service hospital with 24/7 emergency care and trauma center. We deliver advanced surgical care for serious and life-threatening injuries and illnesses. Our care teams listen to quickly understand your health needs and deliver care that's right for you. Ascension Via Christi is a destination for primary care and specialty care - including heart care with a cardiac step-down unit, minimally invasive robotic surgery and women's health. Our OB-GYN maternity care teams at our Birthing Center deliver a personalized birthing experience. We offer a wide range of outpatient procedures, imaging, lab tests, respiratory care and rehabilitation therapies, all on one campus."

During the past decade, Ascension Via Christi - Pittsburg conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 51 clinical trials were completed, i.e. on average, 54.3% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 33 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Via Christi - Pittsburg" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Via Christi - Pittsburg" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Via Christi - Pittsburg" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Recurrent Breast Carcinoma" (5 trials). Many other conditions were trialed in "Ascension Via Christi - Pittsburg" in a lesser frequency.

Most popular intervention types in "Ascension Via Christi - Pittsburg" are "Drug" (108 trials), "Other" (84 trials), "Biological" (68 trials), "Procedure" (41 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Biospecimen Collection" (27 trials), "Quality-of-Life Assessment" (26 trials), "Computed Tomography" (24 trials) and "Nivolumab" (20 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Via Christi - Pittsburg" are 117 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Via Christi - Pittsburg". undefined are not yet recruiting, 30 are recruiting, 75 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Ascension Via Christi - Pittsburg, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Via Christi - Pittsburg, 11 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".